Standard Nuclear IPO Preview: America’s TRISO Fuel Pioneer Files to List
Standard Nuclear manufactures TRISO fuel for advanced reactors at its Oak Ridge, Tennessee facilities.
Many advanced reactor designs, including some small modular reactors and microreactors, require specialized fuel that barely exists at commercial scale in the United States. Standard Nuclear, Inc. (STDN) is asking public investors to bankroll the factory that aims to close that gap.
The Oak Ridge, Tennessee company describes itself as the only company in the United States with industrial-scale manufacturing facilities for TRISO (tristructural-isotropic) fuel, the ceramic-coated particle fuel that many advanced reactor designs are built around. It has filed to raise roughly $328 million to $383 million on the New York Stock Exchange under the ticker STDN.
The pitch is a classic picks-and-shovels bet on the nuclear revival: rather than build reactors, Standard Nuclear wants to supply the fuel developers will need. The catch is that the company is deeply loss-making, years from full-scale commercial production, and dependent on a US government uranium supply chain that does not yet operate at scale.
Key Points
- Standard Nuclear (STDN) manufactures TRISO fuel for advanced reactors and says it is the only US company with industrial-scale TRISO facilities to date.
- The company is offering 18,250,000 Class A shares at $18.00 to $21.00, targeting roughly $328 million to $383 million in gross proceeds on the NYSE.
- It is not yet in full commercial production, with no large-scale commercial fuel sales and an accumulated deficit of $79.9 million as of March 31, 2026.
- Standard Nuclear was the first recipient of the Department of Energy’s Fuel Line Pilot Program and operates under a DOE Other Transaction Agreement.
- A dual-class structure leaves Founder and Executive Chairman Thomas Hendrix with about 59.5% of voting power, making STDN a controlled company.
Company overview
Standard Nuclear is an advanced nuclear fuel developer headquartered in Oak Ridge, Tennessee, the heart of the United States nuclear complex.1 Its stated mission, in the words of the prospectus, is a simple one.
“Our mission is to supply advanced nuclear fuels that enable safe, reliable and scalable nuclear power generation.”Standard Nuclear, Inc., Form S-1/A
The company is led by Chief Executive Officer Dr. Kurt Terrani, with Thomas Hendrix serving as Founder and Executive Chairman. It will list as an emerging growth company and a non-accelerated filer, and it qualifies as a controlled company under NYSE governance rules because of its founder’s concentrated voting stake.
Standard Nuclear positions itself at a chokepoint in the nuclear supply chain. Reactor developers can design and license a plant, but without fuel they cannot operate it, and the fuel these next-generation designs require is not yet produced commercially in the United States.
TRISO fuel and facilities
TRISO fuel is made from poppyseed-sized particles of enriched uranium, each coated in multiple ceramic layers. The company converts enriched uranium feedstock, including High-Assay Low-Enriched Uranium (HALEU) enriched to between 10% and 20% uranium-235, into finished fuel for small modular reactors and microreactors.
“TRISO fuel is engineered to encapsulate fissile material within multiple protective layers, allowing it to retain radioactive fission products at extremely high temperatures.”Standard Nuclear, Inc., Form S-1/A
The prospectus describes a multi-site plan: an operating Oak Ridge SN-0 line, two near-term sister facilities (SN-TN and SN-ID), the Richland SN-F joint venture with Framatome, and a longer-term SN-TN20 expansion.
SN-TN and SN-ID are expected to come online in the second half of 2026, subject to DOE approvals and readiness reviews. The 40 metric tons of uranium (MTU) per year figure is a longer-term aggregate capacity goal the company expects to reach no earlier than 2030 unless demand accelerates.
| Facility | Location | Role | Status |
|---|---|---|---|
| SN-0 | Oak Ridge, Tennessee | Existing TRISO production line | Operating under DOE authorization |
| SN-TN | Oak Ridge, Tennessee | Industrial-scale TRISO fuel manufacturing | Online targeted H2 2026 (pending DOE approvals) |
| SN-ID | Idaho | Fuel production capacity | Online targeted H2 2026 (pending DOE approvals) |
| SN-F (Richland) | Richland, Washington | Joint venture with Framatome | In development |
| SN-TN20 | Oak Ridge, Tennessee | Longer-term capacity expansion | Planned (no earlier than 2030) |
Financial performance
Standard Nuclear is not yet in full commercial production, and its financials read like it. The prospectus states plainly that the company has “historically incurred significant operating losses and negative cash flows” and has “never sold our products at large-scale commercial levels.”
The accumulated deficit widened from $56.6 million at the end of 2024 to $72.1 million at the end of 2025, and reached $79.9 million by March 31, 2026. Operating cash outflows accelerated as the company built out its facilities, a trajectory that explains the urgency of raising external capital now.
| Metric (USD) | FY 2024 | FY 2025 | Q1 2026 (as of / 3 months to Mar 31) |
|---|---|---|---|
| Accumulated deficit | $56.6 million | $72.1 million | $79.9 million |
| Operating cash flow | ($0.4 million) | ($6.7 million) | ($4.3 million) |
IPO details
The offering is being marketed by a large syndicate of banks. Standard Nuclear is selling 18,250,000 Class A shares at an expected $18.00 to $21.00 each, which would raise roughly $328.5 million to $383.3 million in gross proceeds, or up to about $440.7 million if underwriters exercise their option to buy an additional 2,737,500 shares.
The company says it expects to use net proceeds for working capital and general corporate purposes, which may include sales and marketing, research and development, general and administrative costs, capital expenditures, and possible acquisitions or investments. The S-1 does not allocate specific dollar amounts, and management says it has not yet determined its anticipated expenditures. The preliminary prospectus does not disclose an expected post-offering valuation.
| Detail | Value |
|---|---|
| Expected Ticker | STDN |
| Exchange | New York Stock Exchange (NYSE) |
| Shares Offered | 18,250,000 Class A shares |
| Price Range | $18.00 – $21.00 |
| Over-Allotment Option | 2,737,500 additional shares |
| Estimated Gross Proceeds | ~$328.5 million – $383.3 million (up to ~$440.7 million with over-allotment) |
| Use of Proceeds | Working capital and general corporate purposes (no specific allocation disclosed) |
| Underwriters | BofA Securities, Goldman Sachs & Co. LLC, Barclays, UBS Investment Bank, Evercore ISI, RBC Capital Markets, William Blair, Stifel |
Ownership and funding
Standard Nuclear’s most distinctive relationship is with the United States government. The company was selected as the first recipient of the Department of Energy’s (DOE) Fuel Line Pilot Program, and it entered into an Other Transaction Agreement (OTA) for Fuel Production Line Authorization with the DOE dated September 26, 2025, under which Standard Nuclear operates as a prime contractor to the DOE. Its existing SN-0 production line operates under DOE authorization, while SN-TN and SN-ID are expected to operate under DOE authorization once required approvals and readiness reviews are complete.
Control sits firmly with the founder. The company uses a two-class share structure in which Class A shares carry one vote each and Class B shares carry 20 votes each. Following the offering, Class B shares held by Founder and Executive Chairman Thomas Hendrix will represent about 59.5% of the voting power, or roughly 59.1% if the over-allotment is fully exercised.
That concentration makes Standard Nuclear a controlled company under NYSE standards, meaning it can opt out of certain independent-board requirements. The prospectus does not present a simple cap-table-style list of pre-IPO investors in the sections available for review.
Key risks
The clearest risk is commercial: Standard Nuclear has never sold its products at large-scale commercial levels and continues to burn cash, with an accumulated deficit approaching $80 million. The company reports up to $245 million of total contract backlog, including $65 million that is funded, but reaching profitability still depends on completing its facilities and converting that backlog and pipeline into large-scale commercial deliveries.
Demand is also outside the company’s control. Its customers are advanced reactor developers whose projects are largely pre-deployment, so any delay in reactor commercialization directly delays fuel orders. A slower nuclear buildout would leave Standard Nuclear with capacity and no buyers.
Feedstock is a third bottleneck. For customers whose reactors require HALEU, there is currently no commercial US supply, and that material can presently be sourced only in limited quantities from the DOE. That leaves a critical input to the business gated by government supply that has yet to scale.
Regulatory timing compounds the uncertainty. Operations at the SN-TN and SN-ID facilities require DOE approval of Documented Safety Analyses and readiness reviews expected in the second half of 2026, and those approvals run on the DOE’s schedule rather than the company’s.
Finally, governance concentration is a structural risk. The dual-class structure and controlled-company status mean minority Class A holders will have limited influence over decisions, and the founder’s interests may not always align with theirs.